Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Orbit ; 32(3): 161-5, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23514047

ABSTRACT

PURPOSE: To describe the surgical technique for a novel poly-HEMA (2-hydroxyethyl methacralate)[PHEMA] implant (Alphasphere, Addition Technology, Des Plaines, IL) in primary enucleation and placement of secondary orbital implant. METHODS: Retrospective chart review of all patients receiving an Alphasphere implant for primary enucleation or secondary implant exchange from October 2009 to 2011. Interval follow-up was performed again on January 2013. Patient demographics, indications for surgery, and post-operative complications were reviewed. RESULTS: Twelve patients received an Alphasphere implant for primary enucleation (n = 10) or secondary exchange (n = 2), with follow-up that ranged from 2 weeks to 14 months. The study included 9 adult and 3 pediatric patients with a mean age of 40 years, range 8-82 years. The indication for enucleation included: painful blind eye (n = 9), enophthalmos with difficult prosthesis fit in cases of secondary implant exchange (n = 2), and prophylaxis for sympathetic ophthalmia (n = 1). Only one patient required removal of the implant, due to a sinus infection with subsequent extrusion of the implant. Otherwise, the only other complication experienced was slight implant migration (n = 1). CONCLUSION: This initial report indicates that Alphasphere can be successfully used in the management of an anophthalmic socket. The advantages of the Alphasphere implant include: it does not require tissue wrapping, extraocular muscles can be directly sutured to the implant, it maintains a smooth surface to limit risk of exposure due to conjunctival breakdown, and undergoes anterior orbital fibrovascular ingrowth which optimizes prosthesis location and socket motility.


Subject(s)
Anophthalmos/surgery , Eye Enucleation , Orbital Implants , Prosthesis Implantation/methods , Adolescent , Adult , Aged , Aged, 80 and over , Child , Female , Humans , Male , Middle Aged , Polyhydroxyethyl Methacrylate , Prosthesis Design , Retrospective Studies
2.
J Pediatr Ophthalmol Strabismus ; 49 Online: e66-9, 2012 Dec 04.
Article in English | MEDLINE | ID: mdl-23205877

ABSTRACT

Angiolymphoid hyperplasia with eosinophilia is a rare benign vascular proliferation with lymphocytic and eosinophilic infiltrate. Angiolymphoid hyperplasia with eosinophilia presents as single or multiple dome-shaped papules or plaques involving the dermis and subcutaneous tissues of the head and neck region. Conjunctival angiolymphoid hyperplasia with eosinophilia is rare, with only two previous case reports.


Subject(s)
Angiolymphoid Hyperplasia with Eosinophilia/diagnosis , Conjunctival Diseases/diagnosis , Angiolymphoid Hyperplasia with Eosinophilia/metabolism , Biomarkers/metabolism , Child , Conjunctival Diseases/metabolism , Eosinophils/pathology , Humans , Immunohistochemistry , Intraocular Pressure , Lymphocytes/pathology , Male , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...